Cargando…
Efficacy and Safety of Tapencarium (RZL-012) in Submental Fat Reduction
BACKGROUND: Tapencarium (RZL-012) (5-(3.6-dibromo-9H-carbazol-9-yl)-N, N, N-trimethylpentan-1-aminium chloride) is a novel injectable synthetic molecule with cytolytic properties, capable of reducing subcutaneous fat volume. OBJECTIVES: The goal of this 3-armed, randomized, double-blind, placebo-con...
Autores principales: | Shridharani, Sachin M, Dayan, Steven, Biesman, Brian, Cohen, Joel, Downie, Jeanine, Jones, Derek, Shamban, Ava, Fabi, Sabrina, Yoelin, Steve, Fagien, Steven, Ablon, Glynis, Gold, Michael, Gueta, Racheli, Walker, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501747/ https://www.ncbi.nlm.nih.gov/pubmed/37348516 http://dx.doi.org/10.1093/asj/sjad195 |
Ejemplares similares
-
Tapencarium (RZL-012) for Flank Fat Reduction: A Proof-of-Concept Study
por: Shridharani, Sachin M, et al.
Publicado: (2023) -
Mode of Action of RZL-012, a New Fat-Reducing Molecule
por: Blaugrund, Eran, et al.
Publicado: (2021) -
Effectiveness of Volbella (VYC-15L) for Infraorbital Hollowing: Patient-Reported Outcomes From a Prospective, Multicenter, Single-Blind, Randomized, Controlled Study
por: Fabi, Sabrina, et al.
Publicado: (2023) -
Noninvasive Submental Fat Compartment Treatment
por: Shamban, Ava T.
Publicado: (2016) -
Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations
por: Teller, Craig F., et al.
Publicado: (2021)